Chemed Corp. (CHE) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 26	$5.3	$5.65	+6.6%	—	$657.5M	—
Q4 25	$7.03	$6.42	-8.7%	—	$639.3M	—
Q3 25	$5.37	$5.27	-1.9%	—	$624.9M	—
Q2 25	$4.98	$4.27	-14.3%	—	$618.8M	—
Q1 25	$5.55	$5.63	+1.4%	—	$646.9M	—
Q4 24	$6.78	$6.83	+0.7%	—	$640M	—
Q3 24	$5.76	$5.64	-2.1%	—	$606.2M	—
Q2 24	$5.59	$5.47	-2.1%	—	$595.9M	—
Q1 24	$5.48	$5.2	-5.1%	—	$589.2M	—
Q4 23	$6.25	$6.6	+5.6%	—	$585.9M	—
Q3 23	$4.9	$5.32	+8.6%	—	$564.5M	—
Q2 23	$5.09	$4.71	-7.5%	—	$553.8M	—
Q1 23	$4.81	$4.82	+0.2%	—	$560.2M	—
Q4 22	$5.32	$5.39	+1.3%	—	$546.7M	—
Q3 22	$4.65	$4.74	+1.9%	—	$526.5M	—
Q2 22	$4.78	$4.84	+1.3%	—	$531.3M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$18.4	—	—	$2.5B	—
FY24	—	$20.1	—	—	$2.4B	—
FY23	—	$18.1	—	—	$2.3B	—
FY22	—	$16.7	—	—	$2.1B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$1.6B	$1.7B	$1.8B	$1.9B	$2.1B	$2.1B	$2.1B	$2.3B	$2.4B	$2.5B
YoY change	+2.17%	+5.7%	+6.96%	+8.75%	+7.27%	+2.87%	-0.2%	+6.06%	+7.37%	+4.06%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	1.6B	1.7B	1.8B	1.9B	2.1B	2.1B	2.1B	2.3B	2.4B	2.5B
Cost of revenue	1.1B	1.2B	1.2B	1.3B	1.4B	1.4B	1.4B	1.5B	1.6B	1.7B
Gross profit	461.4M	516.2M	555M	617.4M	701.4M	769.8M	765.1M	798.8M	854.3M	823.2M
Gross margin	29.3%	31%	31.1%	31.8%	33.7%	36%	35.8%	35.3%	35.1%	32.5%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	248.1M	276.7M	271.2M	305.7M	330.2M	366.7M	358.7M	395.1M	424.4M	417.2M
Operating expenses	252.6M	276.7M	271.2M	305.7M	255.1M	366.7M	358.7M	395.1M	424.4M	417.2M
Operating income	178.7M	203.9M	244.9M	266.5M	389.7M	344M	347.2M	342.8M	366.9M	341.2M
Operating margin	11.3%	12.2%	13.7%	13.7%	18.7%	16.1%	16.3%	15.1%	15.1%	13.5%
Non-operating income, net	1.6M	-83.2M	-1M	-881K	8.7M	7.8M	-13.3M	4.4M	19.7M	7.6M
Pretax income	177.1M	116.9M	239.6M	261.6M	396M	350.3M	329.7M	350.4M	399.5M	355.8M
Income tax	68.3M	18.7M	34.1M	41.7M	76.5M	81.8M	80.1M	77.9M	97.5M	90.5M
Net income	108.7M	98.2M	205.5M	219.9M	319.5M	268.6M	249.6M	272.5M	302M	265.2M
Net margin	6.9%	5.89%	11.5%	11.3%	15.4%	12.6%	11.7%	12%	12.4%	10.5%
EBITDA	215.4M	247.7M	284.8M	320.5M	454.9M	412.2M	397.1M	416.6M	464.7M	425.3M
EPS	6.64	6.11	12.8	13.8	20	17.1	16.7	18.1	20.1	18.4
Diluted EPS	6.48	5.86	12.2	13.3	19.5	16.9	16.5	17.9	19.9	18.3

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	564.5M	585.9M	589.2M	595.9M	606.2M	640M	646.9M	618.8M	624.9M	639.3M	657.5M	—
Cost of revenue	362.4M	358.3M	385.1M	389.8M	396.2M	405.9M	430.5M	434.1M	428M	414.2M	441.7M	—
Gross profit	202.2M	227.6M	204.1M	206.1M	210M	234.1M	216.4M	184.7M	196.9M	225.2M	215.8M	—
Gross margin	35.8%	38.8%	34.6%	34.6%	34.6%	36.6%	33.5%	29.8%	31.5%	35.2%	32.8%	—
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	99.6M	105.9M	115.9M	99.6M	102M	104.3M	105.6M	99.4M	105.8M	105.5M	114.3M	—
Operating expenses	99.9M	105.9M	116M	99.7M	102.1M	104.3M	105.6M	99.4M	105.9M	105.5M	114.3M	—
Operating income	86.8M	108.2M	72.3M	90.8M	92.2M	114.3M	94.8M	69M	74.8M	103.6M	84.6M	—
Operating margin	15.4%	18.5%	12.3%	15.2%	15.2%	17.9%	14.6%	11.2%	12%	16.2%	12.9%	—
Non-operating income, net	4.3M	4.3M	8.3M	—	5.6M	3.1M	-831K	1K	6.7M	844K	3.9M	—
Pretax income	93.3M	115.6M	84.5M	93.8M	101M	120.1M	95.7M	71.1M	83.5M	105.4M	88.8M	—
Income tax	18.3M	25.5M	19.5M	22.9M	25.3M	29.8M	23.9M	18.6M	19.3M	28.7M	22.5M	—
Net income	75M	90.1M	65M	70.9M	75.8M	90.3M	71.8M	52.5M	64.2M	76.8M	66.3M	—
Net margin	13.3%	15.4%	11%	11.9%	12.5%	14.1%	11.1%	8.48%	10.3%	12%	10.1%	—
EBITDA	104.8M	131.5M	92.4M	110M	111.5M	153.5M	112M	87.8M	93.5M	132M	102.3M	—
EPS	4.97	5.96	4.3	4.7	5.04	6.08	4.91	3.6	4.46	5.48	4.85	5.14
Diluted EPS	4.93	5.9	4.24	4.65	5	6.02	4.86	3.57	4.46	5.48	4.84	5.13

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	2.6B	3.9B	4.5B	7B	8.5B	8.3B	7.6B	8.8B	8B	6.2B	7.2B
Enterprise value	2.7B	4B	4.6B	7.2B	8.5B	8.6B	7.8B	8.7B	7.9B	6.2B	7.4B
Shares outstanding	16.4M	16.1M	16.1M	16M	16M	15.7M	14.9M	15.1M	15M	14.4M	14.4M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	24.2	39.7	22.1	31.9	26.6	30.9	30.5	32.3	26.4	23.2	27.2
P/S	1.67	2.34	2.55	3.62	4.09	3.88	3.57	3.89	3.27	2.43	2.75
P/B	5.01	7.22	7.69	9.65	9.43	13.3	9.54	7.94	7.11	6.29	8.56
EV/EBITDA	12.6	16.1	16.3	22.5	18.6	20.8	19.6	20.9	17	14.6	17.7
EV/Sales	1.73	2.4	2.6	3.73	4.07	4.01	3.65	3.84	3.26	2.46	2.84
Earnings yield	4.14%	2.52%	4.52%	3.14%	3.76%	3.24%	3.28%	3.1%	3.79%	4.31%	3.68%
FCF yield	3.64%	2.52%	5.15%	3.54%	5.07%	3.01%	3.31%	3.11%	4.62%	5.28%	4.29%
PEG	—	—	—	—	—	—	—	—	—	—	0.64

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	29.3%	31%	31.1%	31.8%	33.7%	36%	35.8%	35.3%	35.1%	32.5%	32.4%
Operating margin	11.3%	12.2%	13.7%	13.7%	18.7%	16.1%	16.3%	15.1%	15.1%	13.5%	13.3%
Net margin	6.9%	5.89%	11.5%	11.3%	15.4%	12.6%	11.7%	12%	12.4%	10.5%	10.6%
ROE	20.7%	18.2%	34.8%	30.3%	35.4%	43.1%	31.3%	24.6%	27%	27.1%	27.1%
ROA	12.4%	10.7%	21.1%	17.3%	22.3%	20%	17.3%	16.3%	18.1%	17.2%	13.5%
ROIC	17.8%	27.2%	31.1%	23.9%	36%	28.9%	27.1%	26.7%	25.7%	24.3%	23.1%
Return on tangible assets	-62.2%	-68.4%	-112.9%	-158%	768.5%	-876.2%	312.1%	85.8%	200.4%	686%	-1.2M%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	0.99	0.91	0.83	0.73	1.1	0.76	0.92	1.61	1.38	1.05	0.91
Quick ratio	0.96	0.88	0.8	0.7	1.08	0.73	0.88	1.57	1.35	1.03	0.83
Debt / equity	0.21	0.19	0.15	0.3	0.15	0.52	0.31	0.14	0.13	0.15	0.35
Debt / assets	0.12	0.11	0.09	0.17	0.09	0.24	0.17	0.09	0.08	0.09	0.15
Net debt / EBITDA	0.43	0.36	0.3	0.65	-0.06	0.71	0.44	-0.26	-0.08	0.16	0.53
Interest coverage	48.7	28.4	49	58.7	169.1	188.5	72.9	113.7	225.4	204.3	181.5
Effective tax rate	38.6%	16%	14.2%	15.9%	19.3%	23.3%	24.3%	22.2%	24.4%	25.4%	25.6%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	96.3	103.8	111	121.4	130.3	136.5	143	150.5	161.8	175.7	188
EPS (basic)	6.64	6.11	12.8	13.8	20	17.1	16.7	18.1	20.1	18.4	18.4
EPS (diluted)	6.48	5.86	12.2	13.3	19.5	16.9	16.5	17.9	19.9	18.3	20.1
Book value per share	32	33.7	36.8	45.5	56.5	39.8	53.5	73.6	74.5	68	63.8
FCF per share	5.84	6.12	14.6	15.5	27	15.9	16.9	18.2	24.5	22.6	27.5
Cash per share	0.93	0.69	0.3	0.39	10.2	2.1	4.97	17.5	11.9	5.18	3.09
Capex per share	—	—	—	—	0.11	0.06	0.16	0.04	0.22	4.36	0.34

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	—	—	—	—	0.08%	0.04%	0.11%	0.03%	0.14%	2.48%	0.18%
Capex / operating cash flow	—	—	—	—	0.35%	0.3%	0.78%	0.2%	0.84%	16.2%	1.05%
Payout ratio	15.1%	17.7%	9.08%	9%	6.6%	8.2%	8.82%	8.62%	8.97%	11.9%	12.1%
Dividend yield	0.63%	0.45%	0.41%	0.28%	0.25%	0.27%	0.29%	0.27%	0.34%	0.51%	0.44%

Yield

0.44%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.70

ex-dividend Aug 17, 2026

Payout ratio

12%

of earnings

Dividend growth

13 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 17, 2026	$0.70
May 28, 2026	$0.60
Feb 23, 2026	$0.60

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$564.5M	$585.9M	$589.2M	$595.9M	$606.2M	$640M	$646.9M	$618.8M	$624.9M	$639.3M	$657.5M	—
YoY change	+7.23%	+7.18%	+5.19%	+7.6%	+7.38%	+9.23%	+9.79%	+3.85%	+3.09%	-0.1%	+1.63%	—

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	15.3M	11.1M	4.8M	6.2M	162.7M	32.9M	74.1M	264M	178.3M	74.5M
Receivables	132M	113.7M	119.5M	143.8M	126.9M	137.2M	139.4M	181.5M	171.2M	182.6M
Inventory	5.8M	5.3M	5.7M	7.5M	7.1M	10.1M	10.3M	12M	8.2M	7.5M
Total current assets	169.9M	176M	159.8M	190.7M	329.4M	230.3M	272.6M	500.8M	394.7M	302.6M
Property, plant & equipment	41.5M	57.5M	65.7M	178M	193.8M	196M	211.5M	199.5M	187.5M	197.6M
Goodwill & intangibles	1.1B	1.1B	1.2B	1.4B	1.4B	1.4B	1.4B	1.4B	1.5B	1.5B
Total assets	880.1M	920M	975.5M	1.3B	1.4B	1.3B	1.4B	1.7B	1.7B	1.5B
Accounts payable	39.6M	48.4M	50.1M	51.1M	54.2M	73M	41.9M	48.3M	44.1M	64.5M
Short-term debt	8.8M	10M	—	39.3M	36.2M	37.9M	44M	54.3M	42.3M	40.9M
Total current liabilities	171.8M	193.5M	191.7M	262.2M	299.1M	302.4M	297.2M	312.1M	285.7M	287.1M
Long-term debt	100M	91.2M	89.2M	176.7M	99.2M	285.6M	203M	100.8M	98.5M	102.9M
Total liabilities	356M	379.7M	384.2M	541.7M	533.7M	719.5M	643.3M	560.2M	549.6M	558.8M
Shareholders' equity	524.1M	540.4M	591.3M	726.6M	901.2M	623.3M	798.7M	1.1B	1.1B	979.4M
Total debt	108.8M	101.2M	89.2M	215.9M	135.4M	323.5M	247M	155.1M	140.8M	143.8M
Net debt	93.4M	90.1M	84.4M	209.8M	-27.3M	290.6M	172.9M	-108.8M	-37.5M	69.2M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Cash & short-term investments	159.9M	—	—	—	—	—	—	—	—	129.8M	74.5M	16.9M
Receivables	120.3M	—	—	—	—	—	—	—	—	215.6M	182.6M	215.5M
Inventory	11.7M	—	—	—	—	—	—	—	—	8.2M	7.5M	7.2M
Total current assets	337.2M	—	—	—	—	—	—	—	—	395.2M	302.6M	274.1M
Property, plant & equipment	335.3M	—	—	—	—	—	—	—	—	332.3M	197.6M	341.3M
Goodwill & intangibles	1.4B	—	—	—	—	—	—	—	—	1.5B	1.5B	1.5B
Total assets	1.5B	—	—	—	—	—	—	—	—	1.6B	1.5B	1.5B
Accounts payable	41.1M	—	—	—	—	—	—	—	—	48.1M	64.5M	65.7M
Short-term debt	38.8M	—	—	—	—	—	—	—	—	42M	40.9M	41.3M
Total current liabilities	302.5M	—	—	—	—	—	—	—	—	292M	287.1M	321.4M
Long-term debt	102.1M	—	—	—	—	—	—	—	—	99.5M	102.9M	195.6M
Total liabilities	553.1M	—	—	—	—	—	—	—	—	546.9M	558.8M	687.8M
Shareholders' equity	952.1M	—	—	—	—	—	—	—	—	1.1B	979.4M	848M
Total debt	140.9M	—	—	—	—	—	—	—	—	141.5M	143.8M	236.9M
Net debt	-19M	—	—	—	—	—	—	—	—	11.7M	69.2M	220.1M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	108.7M	98.2M	205.5M	219.9M	319.5M	268.6M	249.6M	272.5M	302M	265.2M
Depreciation & amortization	34.6M	35.6M	38.9M	45.2M	56.6M	59.1M	59.2M	60.9M	63M	64.8M
Stock-based compensation	10.2M	11.7M	13.1M	14.8M	18.4M	22.5M	26.3M	30.1M	32M	32.7M
Change in working capital	-24.9M	-11.5M	19.8M	11.1M	47.5M	-20.3M	-35.9M	-39.4M	3.9M	24.1M
Operating cash flow	122.9M	138.4M	283.6M	296M	483.9M	306.2M	300.1M	319.5M	393.2M	388.3M
Capital expenditure	—	—	—	—	1.7M	904K	2.3M	640K	3.3M	-62.8M
Investing cash flow	-90K	-3.3M	-52.4M	-137.7M	-2.7M	918K	-2.1M	-3.8M	-94.4M	-63.9M
Dividends paid	-16.4M	-17.4M	-18.7M	-19.8M	-21.1M	-22M	-22M	-23.5M	-27.1M	-31.7M
Share repurchases	-102.3M	-94.6M	-158.9M	-92.6M	-175.6M	-576M	-114.5M	-67.7M	-361.4M	-431.5M
Financing cash flow	-103.4M	-126.2M	-220.6M	-142.7M	-331.4M	-441.8M	-572.9M	-182M	-415.7M	-459.9M
Net change in cash	19.5M	8.9M	10.7M	15.5M	149.8M	-134.7M	-274.9M	133.7M	-116.9M	-135.6M
Free cash flow	95.6M	98.2M	234.3M	248.2M	430.5M	249.9M	252.6M	273.4M	368M	325.5M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Net income	53.4M	75M	90.1M	65M	70.9M	75.8M	90.3M	71.8M	52.5M	64.2M	76.8M	66.3M
Depreciation & amortization	15.1M	15.4M	15.5M	15.8M	15.7M	15.7M	15.8M	16M	16.3M	16.2M	16.3M	16.9M
Stock-based compensation	8.4M	5.5M	7.7M	9M	8.9M	6M	8.1M	9.1M	9.2M	6.1M	8.3M	9.2M
Change in working capital	48.8M	-63.3M	-7.7M	-11.4M	-19.8M	-8.4M	43.4M	-48.2M	60.4M	-922K	12.8M	-877K
Operating cash flow	128.9M	26.7M	106.6M	73.5M	73.3M	89.9M	156.5M	34.8M	139.4M	83.4M	133.5M	88.2M
Capital expenditure	214K	146K	134K	86K	2.8M	144K	255K	112K	368K	-17.4M	-16.3M	-17.1M
Investing cash flow	-121K	-3.8M	109K	-7.2M	-82.4M	-5M	241K	-394K	327K	-17.5M	-16.8M	-37.9M
Dividends paid	-5.7M	-6M	-6.1M	-6M	-6.1M	-7.5M	-7.5M	-7.3M	-7.2M	-8.7M	-8.5M	-8.2M
Share repurchases	-13.4M	-14.3M	-39.9M	-38.5M	-55.8M	-57.8M	-209.3M	-33.2M	-42.9M	-180.8M	-174.6M	-190M
Financing cash flow	-41.9M	-4.9M	-65.7M	-53M	-77.9M	-52M	-219.1M	-46.2M	-51.2M	-189.9M	-172.8M	-109.4M
Net change in cash	86.9M	18.1M	41M	13.3M	-87.1M	32.9M	-62.4M	-11.8M	88.6M	-124M	-56.1M	-59.1M
Free cash flow	115.9M	17.3M	96.8M	72.4M	66.5M	77M	152.2M	19.5M	122.8M	66M	117.2M	71.1M

Date	Ratio
May 12, 2005	2:1
Nov 12, 1981	2:1

Chemed Corp. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history